000 01467 a2200397 4500
005 20250514201822.0
264 0 _c20050719
008 200507s 0 0 spa d
022 _a0034-9887
024 7 _a10.4067/s0034-98872004000400001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFardella, Patricia
245 0 0 _a[Clinical application of the activated partial thromboplastin time (APTT) with modified incubation time for the diagnosis of lupus anticoagulant (LA)].
_h[electronic resource]
260 _bRevista medica de Chile
_cApr 2004
300 _a407-12 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAntiphospholipid Syndrome
_xdiagnosis
650 0 4 _aCase-Control Studies
650 0 4 _aFalse Positive Reactions
650 0 4 _aFemale
650 0 4 _aHeparin
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLupus Coagulation Inhibitor
_xblood
650 0 4 _aPartial Thromboplastin Time
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
_xdiagnosis
650 0 4 _aProthrombin Time
650 0 4 _aSensitivity and Specificity
650 0 4 _aThrombin Time
650 0 4 _aWarfarin
_xtherapeutic use
700 1 _aRustagi, Pradip K
773 0 _tRevista medica de Chile
_gvol. 132
_gno. 4
_gp. 407-12
856 4 0 _uhttps://doi.org/10.4067/s0034-98872004000400001
_zAvailable from publisher's website
999 _c15075688
_d15075688